CIK 0002104204 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Alamar Biosciences, Inc.
Sign in to watch- Ticker
- ALMR
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364899036
- Phone
- 510-626-9888
- Business address
- 47071 BAYSIDE PARKWAY, FREMONT, CA, 94538
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $44,561,405
- in 7 filings
Net −$44,561,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-20 | Luo Yuling Chief Executive Officer | Grant or award | +76,509 | 1,940,574 | ||
| 2026-04-20 | Luo Yuling Chief Executive Officer | Conversion | +1,224,152 | 1,224,152 | ||
| 2026-04-20 | Luo Yuling Chief Executive Officer | Other disposition | −1,224,152 | 0 | ||
| 2026-04-20 | Luo Yuling Chief Executive Officer | Other acquisition | +1,224,152 | 1,224,152 | ||
| 2026-04-20 | Luo Yuling Chief Executive Officer | Conversion · Class A Common Stock | −1,020,742 | 0 | ||
| 2026-04-20 | Luo Yuling Chief Executive Officer | Conversion · Founders Preferred Stock | −366,004 | 0 | ||
| 2026-04-20 | Luo Yuling Chief Executive Officer | Conversion · Series A-1 Preferred Stock | −880,802 | 0 | ||
| 2026-04-20 | Luo Yuling Chief Executive Officer | Conversion · Class A Common Stock | −1,224,152 | 0 | ||
| 2026-04-20 | Luo Yuling Chief Executive Officer | Other disposition · Stock Option (Right to Buy) | −266,311 | 0 | ||
| 2026-04-20 | Luo Yuling Chief Executive Officer | Other acquisition · Stock Option (Right to Buy) | +266,311 | 266,311 | ||
| 2026-04-20 | Luo Yuling Chief Executive Officer | Other disposition · Stock Option (Right to Buy) | −25,310 | 0 | ||
| 2026-04-20 | Luo Yuling Chief Executive Officer | Other acquisition · Stock Option (Right to Buy) | +25,310 | 25,310 | ||
| 2026-04-20 | Luo Yuling Chief Executive Officer | Other disposition · Stock Option (Right to Buy) | −23,986 | 0 | ||
| 2026-04-20 | Luo Yuling Chief Executive Officer | Other acquisition · Stock Option (Right to Buy) | +23,986 | 23,986 | ||
| 2026-04-20 | Luo Yuling Chief Executive Officer | Other disposition · Stock Option (Right to Buy) | −20,023 | 0 | ||
| 2026-04-20 | Luo Yuling Chief Executive Officer | Other acquisition · Stock Option (Right to Buy) | +20,023 | 20,023 | ||
| 2026-04-20 | Luo Yuling Chief Executive Officer | Other disposition · Stock Option (Right to Buy) | −27,700 | 0 | ||
| 2026-04-20 | Luo Yuling Chief Executive Officer | Other acquisition · Stock Option (Right to Buy) | +27,700 | 27,700 | ||
| 2026-04-20 | Luo Yuling Chief Executive Officer | Other disposition · Stock Option (Right to Buy) | −1,033,912 | 0 | ||
| 2026-04-20 | Luo Yuling Chief Executive Officer | Other acquisition · Stock Option (Right to Buy) | +1,033,912 | 1,033,912 |
Page 9 of 13 · 244 trades